Mirexus is pleased to announce the appointment of Dr. Shona McDiarmid to its Board of Directors. Shona brings a unique combination of education and experience to Mirexus which will be instrumental as we continue to build our science and patent platforms for the future.
Shona has extensive experience in the biotechnology and pharmaceutical industries and is currently working as a consultant advising life sciences companies on intellectual property (IP) management strategies. Previously, Shona has been responsible at the VP or Director level for the IP functions of several companies, including BioChemPharma, one of the most successful biotech companies in Canada; Shire Pharmaceuticals, the third largest pharmaceutical company in the UK; Bellus Health a biopharmaceutical development company; and most recently, Pharmascience, the largest pharmaceutical employer in Quebec. She has also served as chief patent counsel for Cambia a non-profit institute based in Queensland, Australia and dedicated to open innovation. In these roles Shona led all global IP activities including competitive intelligence, patent landscaping, patent portfolio management, licensing, freedom to operate and infringement analyses, litigation and a wide range of IP disputes in many jurisdictions. Shona practiced law for a number of years with Bereskin & Parr, a leading intellectual property boutique law firm in Toronto, specializing in the life sciences, pharmaceuticals and biotechnology with a practice in patent filing and prosecution, licensing and litigation of intellectual property matters. Shona is a lawyer and patent agent, with a PhD in biology from the University of Western Ontario, followed by a postdoctoral fellowship at Harvard Medical School, Department of Rheumatology and Immunology.